Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy

Open-label, single-arm trial of levofloxacin and amoxicillin in Helicobacter pylori infection, sponsored by Assiut University. Primary endpoints: Detection of pre treatment antibiotic culture and sensitivity test at 12 months, Detection of vacuolating cytotoxin A and cytotoxin-associated gene A virulent Helicobacter Pylori genotypes by polymerase chain reaction amplification(PCR) at 12 months and 1 more. Started Jan 2024; status: completed.